Phase I/II Study of Linperlisib Plus Chidamide for R/R Peripheral T-cell Lymphoma: a Prospective, Multi-center Study
Clinical trial NCT06083701 · UNKNOWN
Trial details
- NCT number
- NCT06083701
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-25
- Primary completion
- 2024-09-25
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.